Navigation Links
US Patent Office rejects company's claim for bean commonly grown by Latin American farmers
Date:4/30/2008

es, the patent remained in force while the appeal was being considered by the Board of Patent Appeals and Interferences (BPAI). Proctor can still appeal the USPTO decision in the US federal courts, all the way to the Supreme Court venue, a costly move; if he so chooses.

We understand that individuals and companies have a right to patent what are clearly novel agriculture innovations, said Hawtin. But when food crops are involved, particularly crops that have been used for years, governments have a duty to ensure that they have been presented with a clearly distinct and novel discovery and that the plant material used in the research and development was lawfully obtained. Agricultural researchers have a responsibility to make sure that publications are easily available to patent examiners.

CIAT officials said that, while they were concerned about the immediate economic impact of the Enola patent, more broadly, they worried that the patent would establish a precedent threatening public access to plant germplasmthe genetic material that comprises the inherited qualities of an organismheld in trust by CIAT and research centers worldwide.

The CIAT genebank is one of 11 maintained worldwide by the CGIAR, where crop materials such as seeds, stems and tubers are held in trust with the United Nations Food and Agriculture Organization (FAO). The genebanks house a total of about 600,000 plant varieties in publicly accessible collections, which are viewed as the pillar of global efforts to conserve agriculture biodiversity and maintain global food security. Plant breeders in both the public and private sectors are constantly seeking access to these resources to help them breed new types of crop varieties, particularly when existing varieties are threatened by pests or disease.

Hopefully, this case can help guide future reviews of patent applications and future preventive actions on the part of the CGIAR Centers, so that farmers who have bee
'/>"/>

Contact: Ellen Wilson
ewilson@burnesscommunications.com
301-652-1558 ext. 5723
Burness Communications
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. bioMETRX, Inc. Acquires Patent for Biometric Padlock
2. bioMETRX, Inc. Acquires Patent for Biometric Padlock
3. Parus Interactive Awarded Patent for Speech-Activated Remote System Management
4. Patent Issued for e-Smart Technologies, Inc.s First Biometric Match-on-Card Technology
5. Translational research patented first experimental treatment against idiopathic pulmonary fibrosis
6. Cornell patents a pink lily look-alike that blooms all summer long
7. Biotechnology needs 21st century patent system: Expert
8. BIO-key(R) Granted Image Identification System Patent for Award Winning Biometric Technology
9. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
10. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
11. Easton, PA Police Officers Armed With BIO-key(R) Mobile Data Solution Access Information Anytime, Anywhere
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Space agencies join forces to systematically observe climate variables 2Space agencies join forces to systematically observe climate variables 3Senators Who Signed Letter Opposing Public Health Plan Took 2417 7 Million in Campaign Donations from Health Care and Insurance Industries 48233 1VIVUS Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes 48228 1VIVUS Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes 48228 2VIVUS Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes 48228 3VIVUS Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes 48228 4VIVUS Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes 48228 5VIVUS Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes 48228 6VIVUS Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes 48228 7ISTA Pharmaceuticals Announces Positive Results for Phase 2 Study of Low Dose Bromfenac in Dry Eye Disease 4570 1ISTA Pharmaceuticals Announces Positive Results for Phase 2 Study of Low Dose Bromfenac in Dry Eye Disease 4570 2ISTA Pharmaceuticals Announces Positive Results for Phase 2 Study of Low Dose Bromfenac in Dry Eye Disease 4570 3